Overview


According to FutureWise analysis the market for Capillary Blood Collection Devices in 2023 is US$ 2.66 billion, and is expected to reach US$ 4 billion by 2031 at a CAGR of 5.20%.

Capillary blood collection is a method of collecting blood in newborns and children. When compared to other sample procedures, it is painless, straightforward, and uses less blood. Using blood as the patient's sample, capillary blood collection is frequently used for disease diagnosis. Blood collection tubes, strips, and micro sampler devices are examples of capillary blood collection devices. Capillary blood collection devices are devices that are used to collect a capillary sample (blood sample) that is usually taken by pricking the skin. Capillaries are small blood arteries near the skin's surface. They can be employed in a variety of settings, including laboratories and home care. The rising prevalence of chronic diseases among the growing population is expected to be a significant factor driving the market, as is the growing demand for minimally invasive methods. These are the major factors driving the growth of the capillary blood collection devices market over the forecast period. Additionally, the market's overall expansion is aided by increased innovation in automated haematology analyzers. However, the market's expansion is hampered by the significant hazards associated with capillary blood collection equipment and capillary blood assortment technologies. The growing demand for safe blood collection methods is likely to create lucrative market opportunities.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Capillary Blood Collection Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Capillary Blood Collection Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • akaciamedical
  • HTL-STREFA S.A.
  • Sarstedt AGCo. KG.
  • Thermo Fisher
  • BD
  • B. Braun Melsungen AG
  • Cardinal Health
  • Terumo Medical Corporation
  • Chembio Diagnostics, Inc.
  • Owen Mumford Ltd.
  • Neoteryx, LLC.
  • Greiner Bio-One International GmbH
  • Improve Medical
  • KABE LABORTECHNIK GmbH
  • Nipro Europe Group Companies
  • Danaher
  • FL MEDICAL s.r.l.
  • SureScreen Diagnostics Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Ypsomed AG
  • Creative Diagnostics
  • Abbott
  • Vitrex Medical A/S
  • CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
  • BIOMEDOMICS INC.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product

  • Blood Sampling Devices
  • Capillary Blood Collection Devices
  • Rapid Test Cassette
  • Remote Capillary Blood Collection Device
  • Wearable Capillary Blood Collection Device

By Modality

  • Manual Sampling
  • Automated/Autoinjection Sampling

By Mode of Administration

  • Puncture
  • Incision

By Application

  • Cardiovascular Disease
  • Infection and Infectious Disease
  • Respiratory Diseases
  • Cancers
  • Rheumatoid Arthritis
  • Others

By Platform

  • Enzyme Immunoassay Platform (ELISA Platform)
  • PCR Platform
  • Lateral Flow Immunoassay Platform
  • ELTABA Platform
  • Others

By Material

  • Plastic
  • Glass
  • Stainless Steel
  • Others

By Procedure

  • Conventional
  • Point of Care Testing

By Age Group

  • Geriatrics
  • Infant
  • Pediatric
  • Adult

By Test Type

  • Whole Blood Test
  • Dried Blood Spot Tests
  • Plasma/Serum Protein Tests
  • Liver Panel/Liver Profile/Liver Function Tests
  • Comprehensive Metabolic Panel (CMP) Tests
  • Other

By Technology

  • Volumetric Absorptive Microsampling
  • Capillary Electrophoresis-Based Chemical Analysis
  • Others

By End User

  • Laboratories
  • Home Care Setting

By Distribution Channel

  • Direct Tender
  • Retail Sales
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Capillary Blood Collection Devices Market By Product, By Modality, By Mode of Administration, By Application, By Platform, By Material, By Procedure, By Age Group, By Test Type, By Technology, By End User, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Capillary Blood Collection Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Capillary Blood Collection Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Capillary Blood Collection Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Capillary Blood Collection Devices Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Blood Sampling Devices
        2. Capillary Blood Collection Devices
        3. Rapid Test Cassette
        4. Remote Capillary Blood Collection Device
        5. Wearable Capillary Blood Collection Device

  • 8.   Capillary Blood Collection Devices Market, By Modality Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Manual Sampling
        2. Automated/Autoinjection Sampling

  • 9.   Capillary Blood Collection Devices Market, By Mode of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Puncture
        2. Incision

  • 10.   Capillary Blood Collection Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiovascular Disease
        2. Infection and Infectious Disease
        3. Respiratory Diseases
        4. Cancers
        5. Rheumatoid Arthritis
        6. Others

  • 11.   Capillary Blood Collection Devices Market, By Platform Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Enzyme Immunoassay Platform (ELISA Platform)
        2. PCR Platform
        3. Lateral Flow Immunoassay Platform
        4. ELTABA Platform
        5. Others

  • 12.   Capillary Blood Collection Devices Market, By Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Plastic
        2. Glass
        3. Stainless Steel
        4. Others

  • 13.   Capillary Blood Collection Devices Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Conventional
        2. Point of Care Testing

  • 14.   Capillary Blood Collection Devices Market, By Age Group Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Geriatrics
        2. Infant
        3. Pediatric
        4. Adult

  • 15.   Capillary Blood Collection Devices Market, By Test Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Whole Blood Test
        2. Dried Blood Spot Tests
        3. Plasma/Serum Protein Tests
        4. Liver Panel/Liver Profile/Liver Function Tests
        5. Comprehensive Metabolic Panel (CMP) Tests
        6. Other

  • 16.   Capillary Blood Collection Devices Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Volumetric Absorptive Microsampling
        2. Capillary Electrophoresis-Based Chemical Analysis
        3. Others

  • 17.   Capillary Blood Collection Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Laboratories
        2. Home Care Setting

  • 18.   Capillary Blood Collection Devices Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Direct Tender
        2. Retail Sales
        3. Others

  • 19.   North America Capillary Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 20.   Latin America Capillary Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 21.   Europe Capillary Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 22.   Asia Pacific Capillary Blood Collection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 23.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 24.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 25.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. akaciamedical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. HTL-STREFA S.A.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Sarstedt AGCo. KG.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Thermo Fisher
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. BD
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cardinal Health
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Terumo Medical Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
           8.5. Strategic Overview
        9. Chembio Diagnostics, Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Owen Mumford Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Neoteryx, LLC.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12.Greiner Bio-One International GmbH
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13.Improve Medical
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14.KABE LABORTECHNIK GmbH
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15.Nipro Europe Group Companies
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16.Danaher
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17.FL MEDICAL s.r.l.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18.SureScreen Diagnostics Ltd.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19.F. Hoffmann-La Roche Ltd.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20.Ypsomed AG
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21.Creative Diagnostics
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22.Abbott
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23.Vitrex Medical A/S
         23.1. Company Overview
         23.2. Product Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview
        24.CHENGDU RICH SCIENCE INDUSTRY CO., LTD.
         24.1. Company Overview
         24.2. Product Portfolio
         24.3. SWOT Analysis
         24.4. Financial Overview
         24.5. Strategic Overview
        25.BIOMEDOMICS INC.
         25.1. Company Overview
         25.2. Product Portfolio
            25.3. SWOT Analysis
            25.4. Financial Overview
         25.5. Strategic Overview

  • 26.   Pre and Post COVID-24 Impact
    • 1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-24 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by administrations
      5. The overall economic slowdown of the developing and developed nations

  • 27.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients